Inflammatory/Dermatology Program

About Purposeful

Purposeful is an early-stage biotech leveraging an AI platform to identify new therapeutic uses for existing, approved drugs, with a primary focus on rare genetic diseases. The company has established research collaborations with patient foundations and pharmaceutical companies to validate candidates for conditions like Fragile X Syndrome and Glioblastoma. Operating as a private, likely pre-revenue entity, Purposeful aims to significantly reduce the time and cost of drug development by bypassing early-stage safety testing.

Therapeutic Areas